These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 2422605
1. [New prospective diagnostic serum markers in prostatic cancer]. Mirone V, De Bellis G, Prezioso D, Sanseverino R, Iannucci F, Padulano P. Minerva Med; 1986 Mar 31; 77(13):503-4. PubMed ID: 2422605 [No Abstract] [Full Text] [Related]
2. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer. Kuriyama M, Loor R, Wang MC, Lee C, Killian CS, Papsidero LD, Inaji H, Nishiura T, Slack NH, Murphy GP, Chu TM. Int Adv Surg Oncol; 1982 Mar 31; 5():29-49. PubMed ID: 6178696 [No Abstract] [Full Text] [Related]
3. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]. Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S. Hinyokika Kiyo; 1991 Jun 31; 37(6):589-94. PubMed ID: 1716409 [Abstract] [Full Text] [Related]
4. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]. Akimoto S, Akakura K, Shimazaki J. Hinyokika Kiyo; 1988 Aug 31; 34(8):1389-96. PubMed ID: 2461644 [Abstract] [Full Text] [Related]
5. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]. Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J. Hinyokika Kiyo; 1988 Dec 31; 34(12):2129-34. PubMed ID: 2467541 [Abstract] [Full Text] [Related]
7. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer]. Morote Robles J, de Torres Mateos JA, Soler-Roselló A. Actas Urol Esp; 1988 Dec 31; 12(2):152-7. PubMed ID: 2458015 [No Abstract] [Full Text] [Related]
11. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM. J Natl Cancer Inst; 1982 Jan 31; 68(1):99-105. PubMed ID: 6172628 [Abstract] [Full Text] [Related]
12. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]. Yoshiki T, Okada K, Oishi K, Yoshida O. Hinyokika Kiyo; 1987 Dec 31; 33(12):2044-9. PubMed ID: 2452559 [Abstract] [Full Text] [Related]
14. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions. Tarle M. Anticancer Res; 1988 Dec 31; 8(4):569-72. PubMed ID: 2460018 [Abstract] [Full Text] [Related]
15. [Determination of tumor markers in the diagnosis of prostatic cancer]. Casas Terrón E, Mari Ruiz M, Molina Andreu E. Arch Esp Urol; 1993 Mar 31; 46(2):99-103. PubMed ID: 7684585 [Abstract] [Full Text] [Related]
16. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer]. Bauer HW. Med Welt; 1982 Nov 19; 33(46):1616-21. PubMed ID: 6185820 [No Abstract] [Full Text] [Related]
17. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group]. Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E. Hinyokika Kiyo; 1996 Oct 19; 42(10):795-804. PubMed ID: 8951478 [Abstract] [Full Text] [Related]
19. [Elements of the early diagnosis and staging of prostatic cancer. Functional results of radical surgery. Apropos of 50 complete prostatectomies]. Lange D, Bruce W, Grellier P. Ann Urol (Paris); 1990 Oct 19; 24(2):103-8. PubMed ID: 1693480 [Abstract] [Full Text] [Related]
20. [A case of mucinous adenocarcinoma of the prostate]. Ezura M, Kimura N, Nagura H. Gan No Rinsho; 1990 Mar 19; 36(4):563-6. PubMed ID: 1690826 [Abstract] [Full Text] [Related] Page: [Next] [New Search]